查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1696292

全球醫用氣體市場 - 2025 - 2033

Global Medical Gas Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫用氣體市場規模達 189.8 億美元，預計到 2033 年將達到 683.1 億美元，2025-2033 年預測期內的複合年成長率為 13.6%。

醫用氣體是用於各種醫療應用（包括治療、診斷和製藥）的專業類別。其中包括氧氣、一氧化二氮、二氧化碳、氦氣、氮氣和醫用空氣。氧氣用於慢性阻塞性肺病和低氧血症等疾病的呼吸支持，而一氧化二氮則用於外科手術中的麻醉劑。二氧化碳對於微創手術中的充氣至關重要，而氦氣則用於呼吸治療。

氮氣在低溫保存和醫學研究中必不可少，而醫用空氣則用於呼吸機和病人護理環境。由於呼吸系統疾病、外科手術技術和家庭醫療保健產業的不斷擴大，對醫用氣體的需求不斷增加。由於氣體輸送系統和醫療保健基礎設施的創新，預計全球市場將成長。

市場動態：

促進因素與約束因素

呼吸系統疾病盛行率不斷上升

純醫用氣體市場的成長是由慢性阻塞性肺病、氣喘和睡眠呼吸中止症等呼吸系統疾病的日益流行所推動的。由於老齡人口的成長、污染水平的提高、工業排放以及吸煙率的上升，對高純度醫用氣體的需求也在增加。醫療設施、家庭護理服務的擴展以及氣體輸送系統的進步對於純醫用氣體在呼吸治療中的廣泛應用至關重要。

例如，慢性呼吸道疾病（CRD），包括慢性阻塞性肺病、氣喘、肺癌和職業性肺部疾病，是影響 5,500 億成年人並佔所有死亡人數的 7% 的全球重大健康問題。肺癌每年導致另外14億人死亡。五歲以下兒童特別容易患肺部疾病，其中氣喘是最常見的慢性病。儘管 1990 年至 2017 年間慢性疾病的發生率增加了 40%，但慢性疾病受到的關注卻少於其他非傳染性疾病。

因此，慢性呼吸系統疾病（CRD）的日益普及推動了對氧氣治療和吸入治療等醫用氣體的需求，同時醫療保健投資和對 CRD 管理的認知也不斷增加。

嚴格的監管要求

FDA、USP 和 ISO 等組織制定的關於純醫用氣體的生產、儲存和運輸的嚴格規定對市場成長構成了重大挑戰，可能會限制新參與者的進入並影響市場擴張。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

第3章：市場亮點與策略要點

  • 主要趨勢和未來預測

第 4 章：依產品類型分類

  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 5 章：動態

  • 影響因素
    • 驅動程式
      • 呼吸系統疾病盛行率不斷上升
      • 醫用氣體輸送系統的技術進步
    • 限制
      • 嚴格的監管要求
      • 醫用氣體設備和基礎設施成本高昂
    • 機會
      • 增加新興市場的醫療保健投資
    • 影響分析

第6章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 7 章：按產品類型

  • 純氣體
  • 混合氣體
  • 其他

第 8 章：按應用

  • 呼吸治療
  • 心血管治療
  • 麻醉
  • 冷凍手術
  • 其他

第 9 章：按最終用戶

  • 醫院和診所
  • 門診手術中心 (ASC)
  • 家庭醫療保健
  • 製藥及生技公司

第 10 章：區域市場分析與成長機會

第 11 章：簡介

  • 北美洲
    • 各區域關鍵動態
      • 美國
      • 加拿大
  • 歐洲
    • 各區域關鍵動態
      • 德國
      • 英國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區
  • 拉丁美洲
    • 各區域關鍵動態
      • 墨西哥
      • 巴西
      • 阿根廷
      • 拉丁美洲其他地區
  • 亞太
    • 各區域關鍵動態
      • 中國
      • 印度
      • 日本
      • 韓國
      • 亞太其他地區
  • 中東和非洲
    • 各區域關鍵動態

第 12 章：競爭格局與市場定位

第 13 章：競爭概況與主要市場參與者

  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 14 章：公司簡介

  • Air Liquide
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量

第 15 章：財務概況

  • 公司收入
    • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • 林德公司
  • 空氣產品和化學品有限公司
  • 梅塞爾Group Limited
  • SOL集團
  • Matheson Tri-Gas 公司
  • 阿特拉斯·科普柯
  • GCE集團
  • 諾瓦燃氣技術公司
  • Gruppo SIAD（非詳盡名單）

第 16 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 17 章：附錄

簡介目錄
Product Code: MD9412

The global medical gas market reached US$ 18.98 billion in 2024 and is expected to reach US$ 68.31 billion by 2033, growing at a CAGR of 13.6% during the forecast period 2025-2033.

Medical gas is a specialized category used in various medical applications, including therapeutic, diagnostic, and pharmaceutical. It includes oxygen, nitrous oxide, carbon dioxide, helium, nitrogen, and medical air. Oxygen is used for respiratory support in conditions like COPD and hypoxemia, while nitrous oxide is used as an anaesthetic in surgical procedures. Carbon dioxide is crucial for insufflation during minimally invasive surgeries, and helium is used in respiratory treatments.

Nitrogen is essential in cryopreservation and medical research, while medical air is used in ventilators and patient care environments. The demand for medical gases has increased due to respiratory diseases, surgical techniques, and the expanding home healthcare sector. The market is expected to grow globally due to innovations in gas delivery systems and healthcare infrastructure.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Respiratory Disorders

The growth of the pure medical gases market is driven by the increasing prevalence of respiratory diseases like COPD, asthma, and sleep apnea. The demand for high-purity medical gases is also increasing due to the growing elderly population, pollution levels, industrial emissions, and higher smoking rates. The expansion of healthcare facilities, home care services, and advancements in gas delivery systems are crucial for the widespread adoption of pure medical gases for respiratory treatments.

For instance, Chronic respiratory diseases (CRDs), including COPD, asthma, lung cancer, and occupational lung diseases, are significant global health issues affecting 550 billion adults and accounting for 7% of all deaths. Lung cancer contributes to another 1.4 billion deaths annually. Children under five are particularly affected by lung diseases, with asthma being the most common chronic condition. Despite a 40% increase in prevalence between 1990 and 2017, CRDs have received less attention than other NCDs.

Hence, the increasing prevalence of chronic respiratory diseases (CRDs) drives demand for medical gases like oxygen therapy and inhaled treatments, with increased healthcare investments and awareness in CRD management.

Stringent Regulatory Requirements

The strict regulations on the production, storage, and transportation of pure medical gases, set by organizations like the FDA, USP, and ISO, are posing a significant challenge to market growth, potentially limiting new player entry and affecting market expansion.

Segment Analysis

The global medical gas market is segmented based on product type, application, end-user, and region.

Product Type:

The pure gases from product type segment is expected to dominate the medical gas market with the highest market share

The pure gases from the product type segment are expected to dominate the medical gas market with the highest market share.

Pure gases, including oxygen, nitrogen, nitrous oxide, carbon dioxide, and helium, are high-purity, single-component gases used in therapeutic applications, anaesthesia, respiratory treatments, diagnostic imaging, and pharmaceutical manufacturing due to their unique physiological and chemical properties.

The demand for pure medical gases is increasing due to respiratory disorders like COPD and asthma, surgical procedures requiring anaesthesia gases, and biotechnology and pharmaceutical research applications.

Advancements in gas delivery systems, stringent regulatory standards, and the growing adoption of home healthcare services fuel market growth. For instance, in October 2023, Bausch + Lomb Corporation launched its Pure-line gas range in Europe, available in pure or premixed iterations of SF6, C2F6, and C3F8. This is the latest addition to the company's surgical retina portfolio, which includes intraocular dyes for posterior and anterior staining, as well as intraocular dyes for anterior staining.

Geographical Analysis

North America is expected to hold a significant position in the medical gas market with the highest market share

North America is expected to hold a significant position in the medical gas market with the highest market share. The North American medical gas market is fueled by rising respiratory diseases, geriatric populations, and surgical procedures requiring anaesthesia gases. Also, Regulatory support and stringent safety standards ensure the widespread adoption of medical gas systems in hospitals, ambulatory surgical centres, and research facilities.

Moreover, significant partnerships, advancements in healthcare infrastructure, and expanding home healthcare services contribute to market growth. For instance, in March 2025, Meritus Gas Partners partnered with Oxygen Service Company, a leading independent distributor of packaged gases and welding supplies based in Saint Paul, Minnesota. OSC, a 100% employee-owned company, offers a wide range of products and services, including industrial, specialty, and medical gases, automation equipment, and welding and safety supplies.

Competitive Landscape

The major global players in the medical gas market include Air Liquide, Linde plc, Air Products and Chemicals, Inc., Messer Group GmbH, SOL Group, Matheson Tri-Gas, Inc., Atlas Copco, GCE Group, Nova Gas Technologies, and Gruppo SIAD, among others.

Key Developments

  • In January 2025, INOX Air Products, India's largest industrial gases manufacturer, inaugurated the country's first ultra-high purity electronic grade nitrous oxide plant in Manali, Chennai, with a capacity of 1,700 tonnes per annum, ensuring high purity.
  • In July 2024, Adenia Partners acquired Air Liquide's operations in 12 African countries, forming Erium, the first pan-African leader in industrial and medical gases. Erium will replace Air Liquide in Benin, Burkina Faso, Cameroon, Congo, Cote d'Ivoire, Gabon, Ghana, Madagascar, Mali, the Democratic Republic of Congo, Senegal, and Togo.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical gas market report delivers a detailed analysis with 62 key tables, more than 55 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

3. Market Highlights and Strategic Takeaways

  • 3.1. Key Trends and Future Projections

4. Snippet by Product Type

  • 4.1. Snippet by Application
  • 4.2. Snippet by End-User
  • 4.3. Snippet by Region

5. Dynamics

  • 5.1. Impacting Factors
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Disorders
      • 5.1.1.2. Technological Advancements in Medical Gas Delivery Systems
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent Regulatory Requirements
      • 5.1.2.2. High Cost of Medical Gas Equipment and Infrastructure
    • 5.1.3. Opportunity
      • 5.1.3.1. Increasing Healthcare Investments in Emerging Markets
    • 5.1.4. Impact Analysis

6. Strategic Insights and Industry Outlook

  • 6.1. Market Leaders and Pioneers
    • 6.1.1. Emerging Pioneers and Prominent Players
    • 6.1.2. Established leaders with largest selling Brand
    • 6.1.3. Market leaders with established Product
  • 6.2. CXO Perspectives
  • 6.3. Latest Developments and Breakthroughs
  • 6.4. Case Studies/Ongoing Research
  • 6.5. Regulatory and Reimbursement Landscape
    • 6.5.1. North America
    • 6.5.2. Europe
    • 6.5.3. Asia Pacific
    • 6.5.4. Latin America
    • 6.5.5. Middle East & Africa
  • 6.6. Porter's Five Force Analysis
  • 6.7. Supply Chain Analysis
  • 6.8. Patent Analysis
  • 6.9. SWOT Analysis
  • 6.10. Unmet Needs and Gaps
  • 6.11. Recommended Strategies for Market Entry and Expansion
  • 6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 6.13. Pricing Analysis and Price Dynamics
  • 6.14. Key Opinion Leaders

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pure Gases*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gas Mixtures
  • 7.4. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Respiratory Therapy*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Cardiovascular Therapy
  • 8.4. Anesthesia
  • 8.5. Cryosurgery
  • 8.6. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals & Clinics*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Ambulatory Surgical Centers (ASCs)
  • 9.4. Home Healthcare
  • 9.5. Pharmaceutical & Biotechnology Companies

10. Regional Market Analysis and Growth Opportunities

11. Introduction

  • 11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.1. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.6.1. U.S.
      • 11.2.6.2. Canada
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.6.1. Germany
      • 11.3.6.2. U.K.
      • 11.3.6.3. France
      • 11.3.6.4. Spain
      • 11.3.6.5. Italy
      • 11.3.6.6. Rest of Europe
  • 11.4. Latin America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.6.1. Mexico
      • 11.4.6.2. Brazil
      • 11.4.6.3. Argentina
      • 11.4.6.4. Rest of Latin America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.6.1. China
      • 11.5.6.2. India
      • 11.5.6.3. Japan
      • 11.5.6.4. South Korea
      • 11.5.6.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape and Market Positioning

13. Competitive Overview and Key Market Players

  • 13.1. Market Share Analysis and Positioning Matrix
  • 13.2. Strategic Partnerships, Mergers & Acquisitions
  • 13.3. Key Developments in Product Portfolios and Innovations
  • 13.4. Company Benchmarking

14. Company Profiles

  • 14.1. Air Liquide*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio
      • 14.1.2.1. Product Description
      • 14.1.2.2. Product Key Performance Indicators (KPIs)
      • 14.1.2.3. Historic and Forecasted Product Sales
      • 14.1.2.4. Product Sales Volume

15. Financial Overview

  • 15.1. Company Revenue's
    • 15.1.1. Geographical Revenue Shares
      • 15.1.1.1. Revenue Forecasts
    • 15.1.2. Key Developments
      • 15.1.2.1. Mergers & Acquisitions
      • 15.1.2.2. Key Product Development Activities
      • 15.1.2.3. Regulatory Approvals, etc.
    • 15.1.3. SWOT Analysis
  • 15.2. Linde plc
  • 15.3. Air Products and Chemicals, Inc.
  • 15.4. Messer Group GmbH
  • 15.5. SOL Group
  • 15.6. Matheson Tri-Gas, Inc.
  • 15.7. Atlas Copco
  • 15.8. GCE Group
  • 15.9. Nova Gas Technologies
  • 15.10. Gruppo SIAD (LIST NOT EXHAUSTIVE)

16. Assumption and Research Methodology

  • 16.1. Data Collection Methods
  • 16.2. Data Triangulation
  • 16.3. Forecasting Techniques
  • 16.4. Data Verification and Validation

17. Appendix

  • 17.1. About Us and Services
  • 17.2. Contact Us